Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease

Mihardja, M., Roy, J., Wong, K.Y., Aquili, L., Heng, B.C., Chan, Y‐S, Fung, M.L. and Lim, L.W. (2020) Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease. Annals of the New York Academy of Sciences, 1478 (1). pp. 43-62.

Link to Published Version:
*Subscription may be required


Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by the hallmark pathologies of amyloid-beta plaques and neurofibrillary tangles. Symptoms of this devastating disease include behavioral changes and deterioration of higher cognitive functions. Impairment of neurogenesis has also been shown to occur in AD, which adversely impacts new neuronal cell growth, differentiation, and survival. This impairment possibly results from the cumulative effects of the various pathologies of AD. Preclinical studies have suggested that the administration of melatonin—the pineal hormone primarily responsible for the regulation of the circadian rhythm—targets the effects of AD pathologies and improves cognitive impairment. It is postulated that by mitigating the effect of these pathologies, melatonin can also rescue neurogenesis impairment. This review aims to explore the effect of AD pathologies on neurogenesis, as well as the mechanisms by which melatonin is able to ameliorate AD pathologies to potentially promote neurogenesis.

Item Type: Journal Article
Publisher: Blackwell Publishing Inc.
Copyright: © 2020 New York Academy of Sciences.
Item Control Page Item Control Page